🇺🇸 FDA
Pipeline program

Proxalutamide

GT0918-CN-2001

Phase 1 small_molecule completed

Quick answer

Proxalutamide for Metastatic Breast Cancer is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Metastatic Breast Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials